European Patent Office Accepts Medlabs Depression Patent | Breaking News

Be the First to Comment Read

European Patent Office Accepts Medlabs Depression Patent | Breaking News

The European Patent Office has accepted Medlab’s patent after their study showed that using NRGBiotic™ with an antidepressant produced significantly better outcomes than taking the anti-depressant medication alone.

Disclaimer

Speak your Mind

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK